<DOC>
	<DOCNO>NCT02946996</DOCNO>
	<brief_summary>The purpose study look effect study drug ( metformin OPC ) AGE level patient prostate cancer .</brief_summary>
	<brief_title>Study Pharmacologic Manipulation AGE ( Advanced Glycation Endproducts ) Levels Prostate Cancer Patients Receiving Androgen Deprivation Therapy</brief_title>
	<detailed_description>AGEs type metabolite , substance , find food . The AGE content food determine type food eat also prepare food . The researcher help conduct study find potential link AGE level cancer . The purpose study see certain drug ( metformin OPC ) effect AGE level blood see AGE level effect cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Histologic confirmation adenocarcinoma prostate . Subjects may metastatic nonmetastatic disease , may castrationresistant nonresistant . Subjects must receive ADT LHRH agonist antagonist , without antiandrogen . Subjects whose ADT interrupt may enroll continue study long testosterone document remain &lt; 50ng/dL . The ADT treatment must first second line systemic therapy , may give adjuvant therapy , treatment recurrent cancer . Subjects must adequate hematologic , renal , hepatic function baseline , follow : Hematology parameter : ANC &gt; 1500/mcL , platelet &gt; 100,000/mcL , Hgb &gt; 8.0gm/dL Renal Function : Creatinine &lt; 1.8mg/mL Liver Function : Total bilirubin â‰¤ULN , AST ALT &lt; 1.5xULN , Alk phosphatase &lt; 2.5xULN Prior radiation therapy allow Subjects may diabetes mellitus must take metformin . Able swallow retain oral medication ECOG performance status 0 2 Ability sign write informed consent Documented testosterone level must maintain treatment &lt; 50ng/dL Known allergy grape grape seed Known hypersensitivity intolerance metformin . Any condition associate increase risk metforminassociated lactic acidosis ( e.g . congestive heart failure define NYHA Class III IV functional status , history acidosis type ; habitual intake 3 alcoholic beverage per day ) . More two course combination ADT agent , prior chemotherapy metastatic prostate cancer . Current use metformin , strong antioxidant .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>